Schroder Investment Management Group
UTHR icon

Schroder Investment Management Group’s United Therapeutics UTHR Stock Holding History

Schroder Investment Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8M Buy
45,631
+19,438
+74% +$9.68M 0.02% 470
2025
Q4 		$13M Sell
26,193
-4,130
-14% -$1.92M 0.01% 597
2025
Q3 		$12.9M Buy
30,323
+128
+0.4% +$43K 0.01% 615
2025
Q2 		$8.68M Sell
30,195
-62,115
-67% -$18.6M 0.01% 659
2025
Q1 		$28.3M Sell
92,310
-71,472
-44% -$24.5M 0.03% 417
2024
Q4 		$58.6M Sell
163,782
-2,020
-1% -$742K 0.06% 267
2024
Q3 		$59.4M Sell
165,802
-61,007
-27% -$20.6M 0.06% 254
2024
Q2 		$72.3M Buy
226,809
+10,685
+5% +$2.83M 0.08% 208
2024
Q1 		$49.6M Buy
216,124
+28,271
+15% +$6.38M 0.06% 289
2023
Q4 		$41.3M Buy
187,853
+9,848
+6% +$2.27M 0.05% 323
2023
Q3 		$40.2M Buy
178,005
+31,510
+22% +$7.26M 0.06% 299
2023
Q2 		$32.3M Buy
146,495
+2,252
+2% +$499K 0.05% 374
2023
Q1 		$32.3M Buy
144,243
+113,869
+375% +$28.1M 0.05% 361
2022
Q4 		$8.45M Sell
30,374
-27,964
-48% -$7.06M 0.01% 668
2022
Q3 		$12.2M Sell
58,338
-3,809
-6% -$852K 0.02% 560
2022
Q2 		$14.8M Sell
62,147
-25,712
-29% -$5.23M 0.02% 550
2022
Q1 		$15.4M Buy
87,859
+25,996
+42% +$4.95M 0.02% 553
2021
Q4 		$13.4M Sell
61,863
-1,028
-2% -$202K 0.02% 556
2021
Q3 		$11.6M Sell
62,891
-4,278
-6% -$843K 0.02% 600
2021
Q2 		$12.1M Buy
67,169
+12,073
+22% +$2.3M 0.02% 619
2021
Q1 		$9.22M Sell
55,096
-56,252
-51% -$9.38M 0.01% 687
2020
Q4 		$16.9M Sell
111,348
-97,366
-47% -$12.8M 0.02% 522
2020
Q3 		$21.3M Buy
208,714
+13,610
+7% +$1.49M 0.03% 423
2020
Q2 		$23.6M Buy
195,104
+98,902
+103% +$11.1M 0.04% 383
2020
Q1 		$9.21M Buy
+96,202
New +$9.14M 0.02% 557
2019
Q2 		– Sell
-55,559
Closed -$6.52M – 1246
2019
Q1 		$6.52M Sell
55,559
-130,815
-70% -$15.2M 0.01% 651
2018
Q4 		$20.3K Sell
186,374
-38,250
-17% -$4.44M 0.04% 433
2018
Q3 		$28.7M Sell
224,624
-107,675
-32% -$13.3M 0.05% 409
2018
Q2 		$37M Sell
332,299
-48,378
-13% -$5.32M 0.06% 333
2018
Q1 		$42.8M Sell
380,677
-477,518
-56% -$60.7M 0.07% 302
2017
Q4 		$127M Sell
858,195
-190,684
-18% -$24.2M 0.21% 114
2017
Q3 		$125M Sell
1,048,879
-42,796
-4% -$5.47M 0.22% 108
2017
Q2 		$143M Buy
1,091,675
+327,360
+43% +$40.8M 0.26% 90
2017
Q1 		$104M Buy
764,315
+80,338
+12% +$12.2M 0.19% 137
2016
Q4 		$98.1M Buy
683,977
+228,602
+50% +$29.2M 0.19% 135
2016
Q3 		$53.8M Sell
455,375
-34,802
-7% -$4.18M 0.1% 250
2016
Q2 		$51.9M Buy
490,177
+38,024
+8% +$4.24M 0.1% 245
2016
Q1 		$49.7M Buy
452,153
+74,853
+20% +$9.47M 0.1% 248
2015
Q4 		$59.1M Buy
377,300
+352,526
+1,423% +$51.3M 0.12% 204
2015
Q3 		$3.25M Sell
24,774
-50,700
-67% -$8.13M 0.01% 799
2015
Q2 		$12.9M Buy
75,474
+67,774
+880% +$12.2M 0.03% 582
2015
Q1 		$1.33M Sell
7,700
-1,000
-11% -$152K ﹤0.01% 899
2014
Q4 		$1.13M Sell
8,700
-680,149
-99% -$87.6M ﹤0.01% 982
2014
Q3 		$88.6M Sell
688,849
-124,452
-15% -$12.8M 0.12% 166
2014
Q2 		$72M Buy
813,301
+84,300
+12% +$8.11M 0.09% 201
2014
Q1 		$68.5M Sell
729,001
-215,320
-23% -$22M 0.08% 211
2013
Q4 		$107M Buy
944,321
+123,200
+15% +$11.1M 0.13% 136
2013
Q3 		$64.7M Buy
821,121
+11,200
+1% +$819K 0.16% 163
2013
Q2 		$53.3M Buy
+809,921
New +$52.2M 0.14% 181

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Schroder Investment Management Group's UTHR Position: Q1 2026 in Review

Schroder Investment Management Group increased its United Therapeutics (UTHR) stake by 74% in Q1 2026, buying an estimated $9.68M and bringing the position to 45,631 shares worth $26.8M. The position accounts for 0.02% of the portfolio, ranked #470.

Schroder Investment Management Group first reported a position in UTHR in Q2 2013 and has held it in 49 quarters since. The position peaked at $143M in Q2 2017. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Schroder Investment Management Group held 45,631 shares of United Therapeutics worth $26.8M as of Q1 2026.
  • Schroder Investment Management Group bought 19,438 United Therapeutics shares in Q1 2026, an estimated $9.68M.
  • United Therapeutics made up 0.02% of Schroder Investment Management Group's portfolio in Q1 2026, its #470 holding.
  • Schroder Investment Management Group first reported a position in United Therapeutics in Q2 2013 and has held it in 49 quarters since.
  • Schroder Investment Management Group's United Therapeutics position peaked at $143M in Q2 2017.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.